APO Research

APO RESEARCH · REPORT

Pet Disease Diagnostic Reagent

Selected research

Market Structure

Global Pet Disease Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Pet Disease Diagnostic Reagent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Disease Diagnostic Reagent include Nanjing Synthgene Medical Technology, USTAR BIOTECHNOLOGIES (HANGZHOU), Hangzhou LifeReal Biotechnology, Harbin Guosheng Biomedical Laboratory, Idvet, IDEXX, Diogene and Bio-Rad, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Disease Diagnostic Reagent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Disease Diagnostic Reagent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Disease Diagnostic Reagent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Disease Diagnostic Reagent market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Disease Diagnostic Reagent Segment by Company

Nanjing Synthgene Medical Technology

USTAR BIOTECHNOLOGIES (HANGZHOU)

Hangzhou LifeReal Biotechnology

Harbin Guosheng Biomedical Laboratory

Idvet

IDEXX

Diogene

Bio-Rad

Pet Disease Diagnostic Reagent Segment by Type

Nucleic Acid Detection Reagents

Colloidal Gold Detection Reagents

Enzyme-linked Immunosorbent Assay Reagents

Fluorescent PCR Detection Reagents

Pet Disease Diagnostic Reagent Segment by Application

Cat

Dog

Others

Pet Disease Diagnostic Reagent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Diagnostic Reagent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Disease Diagnostic Reagent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Disease Diagnostic Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pet Disease Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pet Disease Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pet Disease Diagnostic Reagent Industry Trends Table 2. Pet Disease Diagnostic Reagent Industry Drivers Table 3. Pet Disease Diagnostic Reagent Industry Opportunities and Challenges Table 4. Pet Disease Diagnostic Reagent Industry Restraints Table 5. Global Pet Disease Diagnostic Reagent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pet Disease Diagnostic Reagent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pet Disease Diagnostic Reagent Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pet Disease Diagnostic Reagent Sales Market Share by Manufacturers Table 9. Global Pet Disease Diagnostic Reagent Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pet Disease Diagnostic Reagent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pet Disease Diagnostic Reagent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pet Disease Diagnostic Reagent Manufacturers, Product Type & Application Table 13. Global Pet Disease Diagnostic Reagent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Disease Diagnostic Reagent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nucleic Acid Detection Reagents Table 17. Major Manufacturers of Colloidal Gold Detection Reagents Table 18. Major Manufacturers of Enzyme-linked Immunosorbent Assay Reagents Table 19. Major Manufacturers of Fluorescent PCR Detection Reagents Table 20. Global Pet Disease Diagnostic Reagent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Pet Disease Diagnostic Reagent Sales by Type (2021-2026) & (K Units) Table 22. Global Pet Disease Diagnostic Reagent Sales by Type (2027-2032) & (K Units) Table 23. Global Pet Disease Diagnostic Reagent Sales Market Share by Type (2021-2026) Table 24. Global Pet Disease Diagnostic Reagent Sales Market Share by Type (2027-2032) Table 25. Global Pet Disease Diagnostic Reagent Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Pet Disease Diagnostic Reagent Revenue by Type (2021-2026) & (K Units) Table 27. Global Pet Disease Diagnostic Reagent Revenue by Type (2027-2032) & (K Units) Table 28. Global Pet Disease Diagnostic Reagent Revenue Market Share by Type (2021-2026) Table 29. Global Pet Disease Diagnostic Reagent Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Cat Table 31. Major Manufacturers of Dog Table 32. Major Manufacturers of Others Table 33. Global Pet Disease Diagnostic Reagent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Pet Disease Diagnostic Reagent Sales by Application (2021-2026) & (K Units) Table 35. Global Pet Disease Diagnostic Reagent Sales by Application (2027-2032) & (K Units) Table 36. Global Pet Disease Diagnostic Reagent Sales Market Share by Application (2021-2026) Table 37. Global Pet Disease Diagnostic Reagent Sales Market Share by Application (2027-2032) Table 38. Global Pet Disease Diagnostic Reagent Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Pet Disease Diagnostic Reagent Revenue by Application (2021-2026) & (K Units) Table 40. Global Pet Disease Diagnostic Reagent Revenue by Application (2027-2032) & (K Units) Table 41. Global Pet Disease Diagnostic Reagent Revenue Market Share by Application (2021-2026) Table 42. Global Pet Disease Diagnostic Reagent Revenue Market Share by Application (2027-2032) Table 43. Global Pet Disease Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pet Disease Diagnostic Reagent Sales by Region (2021-2026) & (K Units) Table 45. Global Pet Disease Diagnostic Reagent Sales Market Share by Region (2021-2026) Table 46. Global Pet Disease Diagnostic Reagent Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Pet Disease Diagnostic Reagent Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Pet Disease Diagnostic Reagent Sales by Country (2021-2026) & (K Units) Table 50. North America Pet Disease Diagnostic Reagent Sales by Country (2027-2032) & (K Units) Table 51. Europe Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Pet Disease Diagnostic Reagent Sales by Country (2021-2026) & (K Units) Table 53. Europe Pet Disease Diagnostic Reagent Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Pet Disease Diagnostic Reagent Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Pet Disease Diagnostic Reagent Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales by Country (2027-2032) & (K Units) Table 60. Global Pet Disease Diagnostic Reagent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Pet Disease Diagnostic Reagent Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Pet Disease Diagnostic Reagent Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Pet Disease Diagnostic Reagent Revenue Market Share by Region (2021-2026) Table 64. Global Pet Disease Diagnostic Reagent Revenue Market Share by Region (2027-2032) Table 65. Nanjing Synthgene Medical Technology Company Information Table 66. Nanjing Synthgene Medical Technology Business Overview Table 67. Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Product Portfolio Table 69. Nanjing Synthgene Medical Technology Recent Development Table 70. USTAR BIOTECHNOLOGIES (HANGZHOU) Company Information Table 71. USTAR BIOTECHNOLOGIES (HANGZHOU) Business Overview Table 72. USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Product Portfolio Table 74. USTAR BIOTECHNOLOGIES (HANGZHOU) Recent Development Table 75. Hangzhou LifeReal Biotechnology Company Information Table 76. Hangzhou LifeReal Biotechnology Business Overview Table 77. Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Product Portfolio Table 79. Hangzhou LifeReal Biotechnology Recent Development Table 80. Harbin Guosheng Biomedical Laboratory Company Information Table 81. Harbin Guosheng Biomedical Laboratory Business Overview Table 82. Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Product Portfolio Table 84. Harbin Guosheng Biomedical Laboratory Recent Development Table 85. Idvet Company Information Table 86. Idvet Business Overview Table 87. Idvet Pet Disease Diagnostic Reagent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Idvet Pet Disease Diagnostic Reagent Product Portfolio Table 89. Idvet Recent Development Table 90. IDEXX Company Information Table 91. IDEXX Business Overview Table 92. IDEXX Pet Disease Diagnostic Reagent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. IDEXX Pet Disease Diagnostic Reagent Product Portfolio Table 94. IDEXX Recent Development Table 95. Diogene Company Information Table 96. Diogene Business Overview Table 97. Diogene Pet Disease Diagnostic Reagent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Diogene Pet Disease Diagnostic Reagent Product Portfolio Table 99. Diogene Recent Development Table 100. Bio-Rad Company Information Table 101. Bio-Rad Business Overview Table 102. Bio-Rad Pet Disease Diagnostic Reagent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Bio-Rad Pet Disease Diagnostic Reagent Product Portfolio Table 104. Bio-Rad Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Pet Disease Diagnostic Reagent Distributors List Table 108. Pet Disease Diagnostic Reagent Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Pet Disease Diagnostic Reagent Product Image Figure 2. Global Pet Disease Diagnostic Reagent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Disease Diagnostic Reagent Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Disease Diagnostic Reagent Sales (2021-2032) & (K Units) Figure 5. Global Pet Disease Diagnostic Reagent Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pet Disease Diagnostic Reagent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nucleic Acid Detection Reagents Image Figure 9. Colloidal Gold Detection Reagents Image Figure 10. Enzyme-linked Immunosorbent Assay Reagents Image Figure 11. Fluorescent PCR Detection Reagents Image Figure 12. Global Pet Disease Diagnostic Reagent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Pet Disease Diagnostic Reagent Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pet Disease Diagnostic Reagent Sales Market Share by Type (2021-2032) Figure 15. Global Pet Disease Diagnostic Reagent Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Pet Disease Diagnostic Reagent Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pet Disease Diagnostic Reagent Revenue Market Share by Type (2021-2032) Figure 18. Cat Image Figure 19. Dog Image Figure 20. Others Image Figure 21. Global Pet Disease Diagnostic Reagent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pet Disease Diagnostic Reagent Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pet Disease Diagnostic Reagent Sales Market Share by Application (2021-2032) Figure 24. Global Pet Disease Diagnostic Reagent Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Pet Disease Diagnostic Reagent Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pet Disease Diagnostic Reagent Revenue Market Share by Application (2021-2032) Figure 27. North America Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Pet Disease Diagnostic Reagent Sales Market Share by Country (2021-2032) Figure 29. U.S. Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Pet Disease Diagnostic Reagent Sales Market Share by Country (2021-2032) Figure 34. Germany Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Pet Disease Diagnostic Reagent Sales Market Share by Country (2021-2032) Figure 41. China Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales Market Share by Country (2021-2032) Figure 49. Brazil Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Pet Disease Diagnostic Reagent Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Pet Disease Diagnostic Reagent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Pet Disease Diagnostic Reagent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Pet Disease Diagnostic Reagent Revenue (2021-2032) & (US$ Million) Figure 60. North America Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Pet Disease Diagnostic Reagent Revenue (2021-2032) & (US$ Million) Figure 62. Europe Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Pet Disease Diagnostic Reagent Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Pet Disease Diagnostic Reagent Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pet Disease Diagnostic Reagent Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pet Disease Diagnostic Reagent Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleic Acid Detection Reagents
  • Colloidal Gold Detection Reagents
  • Enzyme-linked Immunosorbent Assay Reagents
  • Fluorescent PCR Detection Reagents
Applications
  • Cat
  • Dog
  • Others
Companies covered
  • Nanjing Synthgene Medical Technology
  • USTAR BIOTECHNOLOGIES (HANGZHOU)
  • Hangzhou LifeReal Biotechnology
  • Harbin Guosheng Biomedical Laboratory
  • Idvet
  • IDEXX
  • Diogene
  • Bio-Rad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Disease Diagnostic Reagent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Disease Diagnostic Reagent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pet Disease Diagnostic Reagent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pet Disease Diagnostic Reagent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pet Disease Diagnostic Reagent Market Dynamics
  1. 2.1 Pet Disease Diagnostic Reagent Industry Trends
  2. 2.2 Pet Disease Diagnostic Reagent Industry Drivers
  3. 2.3 Pet Disease Diagnostic Reagent Industry Opportunities and Challenges
  4. 2.4 Pet Disease Diagnostic Reagent Industry Restraints
3 Pet Disease Diagnostic Reagent Market by Manufacturers
  1. 3.1 Global Pet Disease Diagnostic Reagent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pet Disease Diagnostic Reagent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pet Disease Diagnostic Reagent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pet Disease Diagnostic Reagent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Disease Diagnostic Reagent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pet Disease Diagnostic Reagent Manufacturers, Product Type & Application
  7. 3.7 Global Pet Disease Diagnostic Reagent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Disease Diagnostic Reagent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Disease Diagnostic Reagent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Disease Diagnostic Reagent Tier 1, Tier 2, and Tier 3
4 Pet Disease Diagnostic Reagent Market by Type
  1. 4.1 Pet Disease Diagnostic Reagent Type Introduction
  2. 4.1.1 Nucleic Acid Detection Reagents
  3. 4.1.2 Colloidal Gold Detection Reagents
  4. 4.1.3 Enzyme-linked Immunosorbent Assay Reagents
  5. 4.1.4 Fluorescent PCR Detection Reagents
  6. 4.2 Global Pet Disease Diagnostic Reagent Sales by Type
  7. 4.2.1 Global Pet Disease Diagnostic Reagent Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pet Disease Diagnostic Reagent Sales by Type (2021-2032)
  9. 4.2.3 Global Pet Disease Diagnostic Reagent Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pet Disease Diagnostic Reagent Revenue by Type
  11. 4.3.1 Global Pet Disease Diagnostic Reagent Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pet Disease Diagnostic Reagent Revenue by Type (2021-2032)
  13. 4.3.3 Global Pet Disease Diagnostic Reagent Revenue Market Share by Type (2021-2032)
5 Pet Disease Diagnostic Reagent Market by Application
  1. 5.1 Pet Disease Diagnostic Reagent Application Introduction
  2. 5.1.1 Cat
  3. 5.1.2 Dog
  4. 5.1.3 Others
  5. 5.2 Global Pet Disease Diagnostic Reagent Sales by Application
  6. 5.2.1 Global Pet Disease Diagnostic Reagent Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Disease Diagnostic Reagent Sales by Application (2021-2032)
  8. 5.2.3 Global Pet Disease Diagnostic Reagent Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pet Disease Diagnostic Reagent Revenue by Application
  10. 5.3.1 Global Pet Disease Diagnostic Reagent Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pet Disease Diagnostic Reagent Revenue by Application (2021-2032)
  12. 5.3.3 Global Pet Disease Diagnostic Reagent Revenue Market Share by Application (2021-2032)
6 Global Pet Disease Diagnostic Reagent Sales by Region
  1. 6.1 Global Pet Disease Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Disease Diagnostic Reagent Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Disease Diagnostic Reagent Sales by Region (2021-2026)
  4. 6.2.2 Global Pet Disease Diagnostic Reagent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pet Disease Diagnostic Reagent Revenue by Region
  1. 7.1 Global Pet Disease Diagnostic Reagent Revenue by Region
  2. 7.1.1 Global Pet Disease Diagnostic Reagent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pet Disease Diagnostic Reagent Revenue by Region (2021-2026)
  4. 7.1.3 Global Pet Disease Diagnostic Reagent Revenue by Region (2027-2032)
  5. 7.1.4 Global Pet Disease Diagnostic Reagent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pet Disease Diagnostic Reagent Revenue (2021-2032)
  8. 7.2.2 North America Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pet Disease Diagnostic Reagent Revenue (2021-2032)
  11. 7.3.2 Europe Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pet Disease Diagnostic Reagent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pet Disease Diagnostic Reagent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Nanjing Synthgene Medical Technology
  2. 8.1.1 Nanjing Synthgene Medical Technology Company Information
  3. 8.1.2 Nanjing Synthgene Medical Technology Business Overview
  4. 8.1.3 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Product Portfolio
  6. 8.1.5 Nanjing Synthgene Medical Technology Recent Developments
  7. 8.2 USTAR BIOTECHNOLOGIES (HANGZHOU)
  8. 8.2.1 USTAR BIOTECHNOLOGIES (HANGZHOU) Company Information
  9. 8.2.2 USTAR BIOTECHNOLOGIES (HANGZHOU) Business Overview
  10. 8.2.3 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Product Portfolio
  12. 8.2.5 USTAR BIOTECHNOLOGIES (HANGZHOU) Recent Developments
  13. 8.3 Hangzhou LifeReal Biotechnology
  14. 8.3.1 Hangzhou LifeReal Biotechnology Company Information
  15. 8.3.2 Hangzhou LifeReal Biotechnology Business Overview
  16. 8.3.3 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Product Portfolio
  18. 8.3.5 Hangzhou LifeReal Biotechnology Recent Developments
  19. 8.4 Harbin Guosheng Biomedical Laboratory
  20. 8.4.1 Harbin Guosheng Biomedical Laboratory Company Information
  21. 8.4.2 Harbin Guosheng Biomedical Laboratory Business Overview
  22. 8.4.3 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Product Portfolio
  24. 8.4.5 Harbin Guosheng Biomedical Laboratory Recent Developments
  25. 8.5 Idvet
  26. 8.5.1 Idvet Company Information
  27. 8.5.2 Idvet Business Overview
  28. 8.5.3 Idvet Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Idvet Pet Disease Diagnostic Reagent Product Portfolio
  30. 8.5.5 Idvet Recent Developments
  31. 8.6 IDEXX
  32. 8.6.1 IDEXX Company Information
  33. 8.6.2 IDEXX Business Overview
  34. 8.6.3 IDEXX Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IDEXX Pet Disease Diagnostic Reagent Product Portfolio
  36. 8.6.5 IDEXX Recent Developments
  37. 8.7 Diogene
  38. 8.7.1 Diogene Company Information
  39. 8.7.2 Diogene Business Overview
  40. 8.7.3 Diogene Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Diogene Pet Disease Diagnostic Reagent Product Portfolio
  42. 8.7.5 Diogene Recent Developments
  43. 8.8 Bio-Rad
  44. 8.8.1 Bio-Rad Company Information
  45. 8.8.2 Bio-Rad Business Overview
  46. 8.8.3 Bio-Rad Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Rad Pet Disease Diagnostic Reagent Product Portfolio
  48. 8.8.5 Bio-Rad Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Disease Diagnostic Reagent Value Chain Analysis
  2. 9.1.1 Pet Disease Diagnostic Reagent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Disease Diagnostic Reagent Production Mode & Process
  6. 9.2 Pet Disease Diagnostic Reagent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Disease Diagnostic Reagent Distributors
  9. 9.2.3 Pet Disease Diagnostic Reagent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research